The Clinical Pharmacy Department showcased some of our outstanding Masters students (Theresa Drechsel & Rafael Knauseder) ...

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...

Once the patient is stable and medical causes of an acute delirium have been eliminated ... evaluated to determine the cause of clinical presentation: dementia, mania, substance abuse, depression ...

Perpetual’s directors have been summoned to a board meeting scheduled for late Tuesday, as KKR prepares to rejig a $2.2 billion bid that was stung by a hefty tax bill.

How did I negotiate the emotional minefield of my daughter’s gender transition? By tackling it head-on and learning along the ...

There are a bunch of different categories with various actions that you can take. Some students are chosen to give presentations, which you can then rate as well. Within the game, you can level up as ...

Inc. today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Bristol Myers Squibb (BMS). "We are pleased to see Abecma expansion in the third ...

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net cash provided by operating activities of $743 million in ...